Ashley E Neal1, Christian Stopp2, David Wypij3, David C Bellinger4, Carolyn Dunbar-Masterson2, David R DeMaso5, Jane W Newburger1. 1. Department of Cardiology, Boston Children's Hospital, Boston, MA; Department of Pediatrics, Harvard Medical School, Boston, MA. 2. Department of Cardiology, Boston Children's Hospital, Boston, MA. 3. Department of Cardiology, Boston Children's Hospital, Boston, MA; Department of Pediatrics, Harvard Medical School, Boston, MA; Department of Biostatistics, Harvard School of Public Health, Boston, MA. 4. Department of Neurology, Boston Children's Hospital, Boston, MA; Department of Psychiatry, Boston Children's Hospital, Boston, MA; Department of Neurology, Harvard Medical School, Boston, MA; Department of Psychiatry, Harvard Medical School, Boston, MA. 5. Department of Cardiology, Boston Children's Hospital, Boston, MA; Department of Pediatrics, Harvard Medical School, Boston, MA; Department of Psychiatry, Boston Children's Hospital, Boston, MA; Department of Psychiatry, Harvard Medical School, Boston, MA.
Abstract
OBJECTIVE: To assess health-related quality of life (HRQoL) of adolescents with repaired tetralogy of Fallot (TOF) and whether impairments in HRQoL domains are associated with neurocognitive and medical factors. STUDY DESIGN: Parents of subjects with TOF and healthy referents 13-16 years of age completed the Child Health Questionnaire-Parent Form 50, generating psychosocial (PsS) and physical (PhS) health summary scores. Adolescents completed the Child Health Questionnaire-Child Form 87 and concurrent in-person neurocognitive testing. We analyzed relationships of PsS and PhS scores with neurocognitive performance and medical factors. RESULTS: Compared with referents (n = 85), adolescents with TOF without a genetic diagnosis (n = 66) had lower PsS (50.9 ± 9.4 vs 57.2 ± 4.2, P < .001) and PhS scores (49.4 ± 9.5 vs 55.8 ± 4.9; P < .001). Compared with a normative sample, these adolescents with TOF had similar PsS scores (P = .52) but significantly lower PhS scores (P = .01). Within adolescents with TOF without genetic disorders, lower PsS scores were highly associated with worse neurocognitive measures, particularly the parent-reported Behavior Rating Inventory of Executive Function composite (r = -0.66, P < .001) and Parent Conners' attention deficit-hyperactivity disorder Index T score (r = -0.54, P < .001), whereas associations of PhS scores with neurocognitive measures were weaker. CONCLUSIONS: Psychosocial health status in adolescents with TOF without genetic disorders was worse than in healthy referents without risk factors for brain injury but similar to a normative sample; physical health status was worse in these adolescents than in either comparison group. Within these subjects with TOF, worse psychosocial health status was most highly associated with concurrent executive dysfunction and attention deficit-hyperactivity disorder. Optimizing HRQoL constitutes another indication for attention to neurodevelopment in children with congenital heart disease.
OBJECTIVE: To assess health-related quality of life (HRQoL) of adolescents with repaired tetralogy of Fallot (TOF) and whether impairments in HRQoL domains are associated with neurocognitive and medical factors. STUDY DESIGN: Parents of subjects with TOF and healthy referents 13-16 years of age completed the Child Health Questionnaire-Parent Form 50, generating psychosocial (PsS) and physical (PhS) health summary scores. Adolescents completed the Child Health Questionnaire-Child Form 87 and concurrent in-person neurocognitive testing. We analyzed relationships of PsS and PhS scores with neurocognitive performance and medical factors. RESULTS: Compared with referents (n = 85), adolescents with TOF without a genetic diagnosis (n = 66) had lower PsS (50.9 ± 9.4 vs 57.2 ± 4.2, P < .001) and PhS scores (49.4 ± 9.5 vs 55.8 ± 4.9; P < .001). Compared with a normative sample, these adolescents with TOF had similar PsS scores (P = .52) but significantly lower PhS scores (P = .01). Within adolescents with TOF without genetic disorders, lower PsS scores were highly associated with worse neurocognitive measures, particularly the parent-reported Behavior Rating Inventory of Executive Function composite (r = -0.66, P < .001) and Parent Conners' attention deficit-hyperactivity disorder Index T score (r = -0.54, P < .001), whereas associations of PhS scores with neurocognitive measures were weaker. CONCLUSIONS:Psychosocial health status in adolescents with TOF without genetic disorders was worse than in healthy referents without risk factors for brain injury but similar to a normative sample; physical health status was worse in these adolescents than in either comparison group. Within these subjects with TOF, worse psychosocial health status was most highly associated with concurrent executive dysfunction and attention deficit-hyperactivity disorder. Optimizing HRQoL constitutes another indication for attention to neurodevelopment in children with congenital heart disease.
Authors: A Carla Zomer; Ilonca Vaartjes; Cuno S P Uiterwaal; Enno T van der Velde; Gert-Jan T Sieswerda; Elly M C Wajon; Koos Plomp; Paul F M van Bergen; Carianne L Verheugt; Eva Krivka; Cees J de Vries; Dirk J A Lok; Diederick E Grobbee; Barbara J M Mulder Journal: Am J Cardiol Date: 2012-03-23 Impact factor: 2.778
Authors: J William Gaynor; Marsha Gerdes; Alex S Nord; Judy Bernbaum; Elaine Zackai; Gil Wernovsky; Robert R Clancy; Patrick J Heagerty; Cynthia B Solot; Donna McDonald-McGinn; Gail P Jarvik Journal: J Thorac Cardiovasc Surg Date: 2010-10-15 Impact factor: 5.209
Authors: Bradley S Marino; David Shera; Gil Wernovsky; Ryan S Tomlinson; Abigail Aguirre; Maureen Gallagher; Angela Lee; Catherine J Cho; Whitney Stern; Lauren Davis; Elizabeth Tong; David Teitel; Kathleen Mussatto; Nancy Ghanayem; Marie Gleason; J William Gaynor; Jo Wray; Mark A Helfaer; Judy A Shea Journal: Qual Life Res Date: 2008-05 Impact factor: 4.147
Authors: Linda M Lambert; L LuAnn Minich; Jane W Newburger; Minmin Lu; Victoria L Pemberton; Ellen A McGrath; Andrew M Atz; Mingfen Xu; Elizabeth Radojewski; Darlene Servedio; Brian W McCrindle Journal: Pediatrics Date: 2009-10-19 Impact factor: 7.124
Authors: David R DeMaso; Johanna Calderon; George A Taylor; Jennifer E Holland; Christian Stopp; Matthew T White; David C Bellinger; Michael J Rivkin; David Wypij; Jane W Newburger Journal: Pediatrics Date: 2017-02-01 Impact factor: 7.124
Authors: Lynn A Sleeper; Jeffrey A Towbin; Steven D Colan; Daphne Hsu; Endel J Orav; Matthew S Lemler; Sarah Clunie; Jane Messere; Darlene Fountain; Tracie L Miller; James D Wilkinson; Steven E Lipshultz Journal: J Pediatr Date: 2015-12-22 Impact factor: 4.406
Authors: Caitlin K Rollins; Lisa A Asaro; Alireza Akhondi-Asl; Barry D Kussman; Michael J Rivkin; David C Bellinger; Simon K Warfield; David Wypij; Jane W Newburger; Janet S Soul Journal: J Pediatr Date: 2016-11-09 Impact factor: 4.406
Authors: Victoria K Robson; Christian Stopp; David Wypij; Carolyn Dunbar-Masterson; David C Bellinger; David R DeMaso; Leonard A Rappaport; Jane W Newburger Journal: J Pediatr Date: 2018-09-28 Impact factor: 4.406
Authors: Ariane Marelli; Steven P Miller; Bradley Scott Marino; Angela L Jefferson; Jane W Newburger Journal: Circulation Date: 2016-05-17 Impact factor: 29.690
Authors: Sarah U Morton; Lara Maleyeff; David Wypij; Hyuk Jin Yun; Caitlin K Rollins; Christopher G Watson; Jane W Newburger; David C Bellinger; Amy E Roberts; Michael J Rivkin; P Ellen Grant; Kiho Im Journal: Cereb Cortex Date: 2021-08-26 Impact factor: 5.357